We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

AnaSpec Introduces SensoLyte® a-Synuclein ELISA Assay

Read time: Less than a minute

AnaSpec, EGT Group has announced the release of an ultrasensitive ELISA assay for quantitatingα-synuclein.

The SensoLyte® α-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) provides a convenient and quantitative assay for determining α-Synuclein amount in cell and tissue lysate as well as in body fluids.

Compared to other anti-α-Synuclein ELISA kits on the market, this one-step, mix-and-read assay takes less time to run.

HRP conjugated detection antibody is added simultaneously with the samples and standards during the assay, eliminating extra incubation and washing steps.

α-Synuclein is a major component of Lewy bodies found in affected neurons of patients with Parkinson’s disease.

This protein has a mass of 14.5 kDa (140 amino acids long) and consists of a conserved degenerative amino-terminal domain and an acidic carboxyl-terminal that has a higher sequence divergence.

α-Synuclein is predominantly expressed in brain, specifically in cerebellum, thalamus, neocortex, hippocampus, and striatum regions.

Other tissues also express α-Synuclein but at very low levels. The physiological role of α-Synuclein is not well understood.

However, the presence of imperfect KTKEGV lipid interacting repeats suggests that it may be involved in synaptic vesicle homeostasis.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.